Research Paper Volume 11, Issue 22 pp 10422—10453

Large-scale analyses identify a cluster of novel long noncoding RNAs as potential competitive endogenous RNAs in progression of hepatocellular carcinoma

Figure 6. Expression and survival sifnificance for the six lncRNAs in 158 clinical samples. Expression levels of lncRNAs GBAP1 (A), MCM3AP-AS1 (B), SLC16A1-AS1 (C), C3P1 (D), HNF4A-AS1 (E), and DIO3OS (F) in 158 HCC tissues and adjacent normal tissues. Kaplan-Meier survival curves showed significant OS differences between high- and low-expression of lncRNAs including GBAP1 (G), MCM3AP-AS1 (H), SLC16A1-AS1 (I), C3P1(J), HNF4A-AS1 (K), and DIO3OS (L), and significant PFS differences including GBAP1 (M), MCM3AP-AS1 (N), SLC16A1-AS1 (O), C3P1 (P), HNF4A-AS1 (Q) and DIO3OS (R), as well as significant DmFS differences including GBAP1 (S), MCM3AP-AS1 (T), SLC16A1-AS1 (U), C3P1 (V), HNF4A-AS1 (W) and DIO3OS (X). N =158, Ca = 158; N, normal tissue; Ca, cancer tissue.